Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)
Clinical trial NCT02064920 · COMPLETED
Trial details
- NCT number
- NCT02064920
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-22
- Primary completion
- 2016-07-13
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.